XML 20 R9.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN PARTNERS' CAPITAL - USD ($)
$ in Millions
Total
Partners’ Capital Excluding Noncontrolling Interests
Noncontrolling Interests
Limited Partners
Series A Preferred Units
Partners’ Capital Excluding Noncontrolling Interests
Limited Partners
Series B Preferred Units
Partners’ Capital Excluding Noncontrolling Interests
Limited Partners
Common Units
Partners’ Capital Excluding Noncontrolling Interests
Increase (Decrease) in Partners' Capital            
Impact of adoption of ASU 2017-05 | ASU 2017-05 $ 113         $ 113
Adjusted balance 11,071     $ 1,505 $ 788 8,778
Beginning balance excluding NCI at Dec. 31, 2017 10,958     1,505 788 8,665
Increase (Decrease) in Partners' Capital            
Net income 388          
Net income attributable to PAA 388     74 25 289
Distributions (Note 9) (534)     (74) (25) (435)
Other comprehensive income/(loss) (121)         (121)
Equity-indexed compensation expense 23         23
Other (3)       (1) (2)
Ending balance excluding NCI at Jun. 30, 2018 10,824     1,505 787 8,532
Beginning balance excluding NCI at Mar. 31, 2018 11,036     1,505 787 8,744
Increase (Decrease) in Partners' Capital            
Net income 100          
Net income attributable to PAA 100     37 12 51
Distributions (Note 9) (267)     (37) (12) (218)
Other comprehensive income/(loss) (56)         (56)
Equity-indexed compensation expense 12         12
Other (1)         (1)
Ending balance excluding NCI at Jun. 30, 2018 10,824     1,505 787 8,532
Beginning balance at Dec. 31, 2018 12,002 $ 12,002   1,505 787 9,710
Beginning balance excluding NCI at Dec. 31, 2018 12,002          
Increase (Decrease) in Partners' Capital            
Net income 1,418 1,416 $ 2 74 25 1,317
Net income attributable to PAA 1,416          
Distributions (Note 9) (579) (579)   (74) (25) (480)
Other comprehensive income/(loss) 109 109       109
Equity-indexed compensation expense 7 7       7
Sale of noncontrolling interest in a subsidiary (Note 9) 128 (2) 130     (2)
Other (12) (12)       (12)
Ending balance excluding NCI at Jun. 30, 2019 12,941          
Ending balance at Jun. 30, 2019 13,073 12,941 132 1,505 787 10,649
Beginning balance at Mar. 31, 2019 12,762 12,762   1,505 787 10,470
Increase (Decrease) in Partners' Capital            
Net income 448 446 2 37 12 397
Net income attributable to PAA 446          
Distributions (Note 9) (311) (311)   (37) (12) (262)
Other comprehensive income/(loss) 51 51       51
Equity-indexed compensation expense 4 4       4
Sale of noncontrolling interest in a subsidiary (Note 9) 128 (2) 130     (2)
Other (9) (9)       (9)
Ending balance excluding NCI at Jun. 30, 2019 12,941          
Ending balance at Jun. 30, 2019 $ 13,073 $ 12,941 $ 132 $ 1,505 $ 787 $ 10,649